1. Granholm AC, Bimonte-Nelson HA, Moore AB, Nelson ME, Freeman LR, Sambamurti K. Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J Alzheimers Dis. 2008 Jun; 14(2): 133-45. 2. Ullrich C, Pirchl M, Humpel C. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. Mol Cell Neurosci. 2010 Dec; 45(4): 408-17. doi: 10.1016/j.mcn.2010.08.001 3. Bhutada P, Mundhada Y, Bansod K, Bhutada C, Tawari S, Dixit P, Mundhada D. Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats. Neurobiol Learn Mem. 2010 Oct; 94(3): 293-302. doi: 10.1016/j.nlm.2010.06.008 4. Jakulj L, Vissers MN, Groen AK, Hutten BA, Lutjohann D, Veltri EP, et al. Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial. J Lipid Res. 2010 Apr; 51(4): 755-62. doi: 10.1194/jlr.M001487 5. Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 2002 Nov; 420(6911): 78-84. doi: 10.1038/nature01158 6. Adams SP, Tsang M, Wright JM. Lipid lowering efficacy of atorvastatin. Cochrane Database Syst Rev. 2012 Dec; 12: CD008226. doi: 10.1002/14651858 7. Lu Y, Cheng Z, Zhao Y, Chang X, Chan C, Bai Y, et al. Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis. Atherosclerosis. 2016 Nov; 254: 215-27. doi: 10.1016/j.atherosclerosis.2016.10.025 8. Can ÖD, Ulupınar E, Özkay ÜD, Yegin B, Öztürk Y. The effect of simvastatin treatment on behavioral parameters, cognitive performance, and hippocampal morphology in rats fed a standard or a high-fat diet. Behav Pharmacol. 2012 Sep; 23(5-6): 582-92. doi: 10.1097/FBP.0b013e328356c3f2 9. Vaughan CJ, Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke. 1999 Sep; 30(9): 1969-73. 10. Baytan SH, Alkanat M, Okuyan M, Ekinci M, Gedikli E, Ozeren M, et al. Simvastatin impairs spatial memory in rats at a specific dose level. Tohoku J Exp Med. 2008 Apr; 214(4): 341-49. 11. Ashrafpour M, Parsaei S, Sepehri H. Quercetin improved spatial memory dysfunctions in rat model of intracerebroventricular streptozotocin-induced sporadic Alzheimer’s disease. Natl J Physiol Pharm Pharmacol. 2015; 5(5): 411-15. doi: 10.5455/njppp.2015.5.2308201563 12. Srinivasan K, Patole PS, Kaul CL, Ramarao P. Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol. 2004 Jun; 26(5): 327-33. 13. Mazza F, Stefanutti C, Di Giacomo S, Vivenzio A, Fraone N, Mazzarella B, et al. Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia. Am J Cardiovasc Drugs. 2008; 8(4): 265-70. doi: 10.2165/00129784-200808040-00006 14. Margdari A, Ebrahimi S, Sepehri H. Effect of Simvastatin on Spatial Memory of Rats Receiving a High-Fat Diet. Journal of Clinical and Basic Research. 2017; 1(2): 21-28. 15. Pistell PJ, Morrison CD, Gupta S, Knight AG, Keller JN, Ingram DK, et al. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol. 2010 Feb; 219(1-2): 25-32. doi: 10.1016/j.jneuroim.2009.11.010 16. Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy. 2003 Jul; 23(7): 871-80. 17. Parle M, Singh N. Reversal of memory deficits by Atorvastatin and Simvastatin in rats. Yakugaku Zasshi. 2007 Jul; 127(7): 1125-37. 18. Balduini W, De Angelis V, Mazzoni E, Cimino M. Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury. Stroke. 2001 Sep; 32(9): 2185-91. 19. Wagner AH, Köhler T, Rückschloss U, Just I, Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol. 2000 Jan; 20(1): 61-69. 20. Kirsch C, Eckert GP, Mueller WE. Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol. 2003 Mar; 65(5): 843-56. 21. Prajapati S, Desai CK, Dikshit RK. An evaluation of the effect of atorvastatin on memory and psychomotor functions in hypertensive patients. J Postgrad Med. 2011 Oct-Dec; 57(4): 291-97. doi: 10.4103/0022-3859.90078 22. Willis RA, Folkers K, Tucker JL, Ye CQ, Xia LJ, Tamagawa H. Lovastatin decreases coenzyme Q levels in rats. Proc Natl Acad Sci U S A. 1990 Nov; 87(22): 8928-30. 23. Sehar N, Agarwal NB, Vohora D, Raisuddin S. Atorvastatin prevents development of kindling by modulating hippocampal levels of dopamine, glutamate, and GABA in mice. Epilepsy Behav. 2015 Jan; 42: 48-53. doi: 10.1016/j.yebeh.2014.11.011 24. Kalayci R, Kaya M, Elmas I, Arican N, Ahishali B, Uzun H, et al. Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats. Brain Res. 2005 May; 1042(2): 184-93. doi: 10.1016/j.brainres.2005.02.044 25. Thabit A, Alhifany A, Alsheikh R, Namnqani S, Al-Mohammadi A, Elmorsy S, et al. Effect of simvastatin and Atorvastatin on serum Vitamin D and bone mineral density in hypercholesterolemic patients: A Cross-Sectional Study. Journal of Osteoporosis. Volume 2014, Article ID 468397. http://dx.doi.org/10.1155/2014/468397
|